Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx

This article originally appeared here.
Share this content:
Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx
Overall Survival in Mantle Cell Lymphoma Up With Deferred Tx

TUESDAY, May 24, 2016 (HealthDay News) -- For patients with mantle cell lymphoma (MCL), deferred therapy seems safe and is an independent predictor of overall survival, according to a study published online May 6 in Cancer.

Jonathon B. Cohen, M.D., from Emory University in Atlanta, and colleagues examined the role of deferred therapy in MCL in a cohort of 8,029 patients. Overall, 6 percent of the patients received deferred therapy (time from diagnosis to treatment >90 days; median time to treatment, 121 days).

The researchers found that patients who deferred therapy were more likely to have stage I or II disease and extranodal involvement; they were also less likely to have B symptoms. The likelihood of being treated at a high-volume teaching/research institution was increased for deferred patients, and they were more likely to reside in the Northeast or West region. For all patients with MCL, deferred therapy was an independent predictor of overall survival. Predictors of improved overall survival among patients who deferred therapy included male sex, younger age, and a lack of comorbidities.

"Deferred therapy is a safe option for a subset of patients with MCL," the authors write. "Further study is required to better identify the best candidates for deferred therapy according to baseline risk stratification in MCL."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Factors ID'd to Predict Fatty Liver in Obese Teens

Factors ID'd to Predict Fatty Liver in Obese ...

African-American obese teens more susceptible to fatty liver effects on glucose metabolism

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients perceive F2F physicians as more compassionate and better communicators

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Absolute risks for colorectal cancer, CRC death not reduced for screening group vs. controls in women

is free, fast, and customized just for you!

Already a member?

Sign In Now »